{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:51:33Z","timestamp":1782478293753,"version":"3.54.5"},"update-to":[{"DOI":"10.1002\/14651858.cd003595","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T00:00:00Z","timestamp":1232496000000}}],"reference-count":53,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003595.pub2","type":"journal-article","created":{"date-parts":[[2009,2,3]],"date-time":"2009-02-03T11:00:32Z","timestamp":1233658832000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura"],"prefix":"10.1002","volume":"2010","author":[{"given":"Mini","family":"Michael","sequence":"first","affiliation":[{"name":"Texas Children's Hospital\/Baylor College of Medicine; Renal Section, Department of Pediatrics; 6621 Fannin St MC 3-2482 Houston Texas USA 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J","family":"Elliott","sequence":"additional","affiliation":[{"name":"The Children's Hospital at Westmead; The University of Sydney; Department of Paediatrics and Child Health, Director of Centre for Evidence Based Paediatric Gastroenterology and Nutrition (CEBPGAN); Locked Bag 4001 Westmead NSW Australia 2145"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta F","family":"Ridley","sequence":"additional","affiliation":[{"name":"The Children's Hospital at Westmead; Australian Paediatric Surveillance Unit; Locked Bag 4001 Westmead NSW Australia 2145"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth M","family":"Hodson","sequence":"additional","affiliation":[{"name":"The Children's Hospital at Westmead; Centre for Kidney Research; Locked Bag 4001 Westmead NSW Australia 2145"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C","family":"Craig","sequence":"additional","affiliation":[{"name":"The Children's Hospital at Westmead; Centre for Kidney Research; Locked Bag 4001 Westmead NSW Australia 2145"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,21]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD003595.pub2-BIB0001|cit1","first-page":"429","article-title":"Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP","volume":"82","author":"Bobbio-Pallavicini","year":"1997","journal-title":"Haematologica"},{"issue":"1","key":"10.1002\/14651858.CD003595.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0955-3886(92)90123-X","article-title":"Thrombotic thrombocytopenic purpura: Clinical results of a French controlled trial","volume":"13","author":"Henon","year":"1992","journal-title":"Transfusion Science"},{"issue":"1","key":"10.1002\/14651858.CD003595.pub2-BIB0003|cit3","first-page":"15","article-title":"Treatment of childhood hemolytic-uremic syndrome with urokinase. Cooperative controlled trial","volume":"41","author":"Loirat","year":"1984","journal-title":"Archives Francaises de Pediatrie"},{"issue":"3","key":"10.1002\/14651858.CD003595.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00858677","article-title":"Treatment of the childhood haemolytic uraemic syndrome with plasma. A multicentre randomized controlled trial. The French Society of Paediatric Nephrology","volume":"2","author":"Loriat","year":"1988","journal-title":"Pediatric Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD003595.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s004670050413","article-title":"Steroids in the hemolytic uremic syndrome","volume":"12","author":"Perez","year":"1998","journal-title":"Pediatric Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD003595.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0022-3476(88)80071-4","article-title":"Plasma infusion for hemolytic-uremic syndrome in children: results of a multicenter controlled trial","volume":"112","author":"Rizzoni","year":"1988","journal-title":"Journal of Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD003595.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group","volume":"325","author":"Rock","year":"1991","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003595.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2141.2005.05418.x","article-title":"Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet","volume":"129","author":"Rock","year":"2005","journal-title":"British Journal of Haematology"},{"issue":"5","key":"10.1002\/14651858.CD003595.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1526-0968.2000.004005327.x","article-title":"Design of the prospective randomized study for the treatment of patients with thrombotic microangiopathy. PRODROMI Study Group","volume":"4","author":"Rothele","year":"2000","journal-title":"Therapeutic Apheresis"},{"issue":"10","key":"10.1002\/14651858.CD003595.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/jama.290.10.1337","article-title":"Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial","volume":"290","author":"Trachtman","year":"2003","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD003595.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0022-3476(88)80031-3","article-title":"Heparin plus dipyridamole in childhood hemolytic-uremic syndrome: a prospective, randomized study","volume":"113","author":"Damme-Lombaerts","year":"1988","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD003595.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0022-3476(73)80490-1","article-title":"Heparin therapy in the hemolytic uremic syndrome","volume":"83","author":"Vitacco","year":"1973","journal-title":"Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD003595.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jca.1003","article-title":"Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP)","volume":"16","author":"Zeigler","year":"2001","journal-title":"Journal of Clinical Apheresis"},{"issue":"5","key":"10.1002\/14651858.CD003595.pub2-BIB0014|cit14","first-page":"446","article-title":"Efficacy of therapeutic plasma exchange in haemolytic uraemic syndrome in childhood [abstract]","volume":"4","author":"Muller-Wiefel","year":"1989","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD003595.pub2-BIB0015|cit15","unstructured":"Thomson PD Milnor LS A randomly selected trial of vitamin E in the haemolytic uraemic syndrome (HUS) [abstract] Xth International Congress of Nephrology; 1987 Jul 26-31; London (UK) 1987 98"},{"issue":"4","key":"10.1002\/14651858.CD003595.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1365-2141.2003.04049.x","article-title":"Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias","volume":"120","author":"Allford","year":"2003","journal-title":"British Journal of Haematology"},{"issue":"7","key":"10.1002\/14651858.CD003595.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1086\/319269","article-title":"The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings","volume":"183","author":"Banatvala","year":"2001","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD003595.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1056\/NEJM199708073370604","article-title":"Surveillance for Escherichia coli O157:H7 infections in Minnesota by molecular subtyping","volume":"337","author":"Bender","year":"1997","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003595.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1182\/blood-2002-02-0344","article-title":"Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura","volume":"100","author":"Bianchi","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD003595.pub2-BIB0020|cit20","first-page":"219","article-title":"Exchange transfusions in the treatment of thrombotic thrombocytopenic purpura","volume":"13","author":"Bukowski","year":"1976","journal-title":"Seminars in Hematology"},{"issue":"25","key":"10.1002\/14651858.CD003595.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJM197712222972507","article-title":"Treatment of thrombotic thrombocytopenic purpura with plasma","volume":"297","author":"Byrnes","year":"1977","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003595.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"294","DOI":"10.7326\/0003-4819-125-4-199608150-00006","article-title":"Splenectomy done during hematologic remission to prevent relapse in patients with thrombotic thrombocytopenic purpura","volume":"125","author":"Crowther","year":"1996","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003595.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1017\/S0950268899003623","article-title":"Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France","volume":"124","author":"Decludt","year":"2000","journal-title":"Epidemiology & Infection"},{"issue":"6964","key":"10.1002\/14651858.CD003595.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1136\/bmj.309.6964.1286","article-title":"Identifying relevant studies for systematic reviews","volume":"309","author":"Dickersin","year":"1994","journal-title":"BMJ"},{"issue":"8825","key":"10.1002\/14651858.CD003595.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0140-6736(92)92869-H","article-title":"Vincristine for thrombotic thrombocytopenic purpura","volume":"340","author":"Durand","year":"1992","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD003595.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/adc.85.2.125","article-title":"Nationwide study of haemolytic uraemic syndrome: clinical microbiological, and epidemiological features","volume":"85","author":"Elliott","year":"2001","journal-title":"Archives of Disease in Childhood"},{"issue":"6","key":"10.1002\/14651858.CD003595.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1182\/blood-2005-03-0848","article-title":"Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases","volume":"106","author":"Fakhouri","year":"2005","journal-title":"Blood"},{"issue":"22","key":"10.1002\/14651858.CD003595.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003595.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jca.20091","article-title":"Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine\/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders","volume":"21","author":"George","year":"2006","journal-title":"Journal of Clinical Apheresis"},{"issue":"7414","key":"10.1002\/14651858.CD003595.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"7211","key":"10.1002\/14651858.CD003595.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised controlled trials","volume":"319","author":"Hollis","year":"1999","journal-title":"BMJ"},{"issue":"7","key":"10.1002\/14651858.CD003595.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"834","DOI":"10.5858\/2003-127-834-TTPAHU","article-title":"Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases","volume":"127","author":"Hosler","year":"2003","journal-title":"Archives of Pathology & Laboratory Medicine"},{"key":"10.1002\/14651858.CD003595.pub2-BIB0033|cit33","article-title":"Hemolytic uremic syndrome in families","volume-title":"Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura","author":"Kaplan","year":"1995"},{"key":"10.1002\/14651858.CD003595.pub2-BIB0034|cit34","first-page":"3","article-title":"Thrombotic microangiopathy: A proposal for a new terminology for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura","volume":"8","author":"Kaplin","year":"1995","journal-title":"Journal of Nephrology"},{"key":"10.1002\/14651858.CD003595.pub2-BIB0035|cit35","unstructured":"Lefebvre C McDonald S Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE Fourth International Cochrane Colloquium; 1996 Oct 20-24; Adelaide (Australia) 1996"},{"issue":"17","key":"10.1002\/14651858.CD003595.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJM199010253231703","article-title":"The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota","volume":"323","author":"Martin","year":"1990","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003595.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0749-0704(03)00010-1","article-title":"Renal failure and renal replacement therapy","volume":"19","author":"Maxvold","year":"2003","journal-title":"Critical Care Clinics"},{"issue":"7","key":"10.1002\/14651858.CD003595.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/adc.65.7.716","article-title":"Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects","volume":"65","author":"Milford","year":"1990","journal-title":"Archives of Disease in Childhood"},{"issue":"9128","key":"10.1002\/14651858.CD003595.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD003595.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/adc.76.6.518","article-title":"Heterogeneity of atypical haemolytic uraemic syndromes","volume":"76","author":"Neuhaus","year":"1997","journal-title":"Archives of Disease in Childhood"},{"issue":"1","key":"10.1002\/14651858.CD003595.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ki.1995.261","article-title":"The hemolytic uremic syndrome","volume":"48","author":"Remuzzi","year":"1995","journal-title":"Kidney International"},{"issue":"2","key":"10.1002\/14651858.CD003595.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2141.1996.d01-1800.x","article-title":"Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group","volume":"94","author":"Rock","year":"1996","journal-title":"British Journal of Haematology"},{"issue":"2","key":"10.1002\/14651858.CD003595.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0022-3476(05)80730-9","article-title":"Epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988. The Canadian Pediatric Kidney Disease Reference Centre","volume":"119","author":"Rowe","year":"1991","journal-title":"Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD003595.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1046\/j.1523-1755.2001.060003831.x","article-title":"Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura","volume":"60","author":"Ruggenenti","year":"2001","journal-title":"Kidney International"},{"issue":"Suppl 95","key":"10.1002\/14651858.CD003595.pub2-BIB0045|cit45","first-page":"63S","article-title":"Solvent detergent-treated plasma versus fresh frozen plasma in patients with TTP","volume":"36","author":"Sacher","year":"1996","journal-title":"Transfusion"},{"issue":"5","key":"10.1002\/14651858.CD003595.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD003595.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-2001-15247","article-title":"Hemolytic-uremic syndrome and complement factor H deficiency: clinical aspects","volume":"27","author":"Taylor","year":"2001","journal-title":"Seminars in Thrombosis & Hemostasis"},{"issue":"2","key":"10.1002\/14651858.CD003595.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ajh.2830500203","article-title":"Increasing mortality from thrombotic thrombocytopenic purpura in the United States - analysis of national mortality data, 1968-1991","volume":"50","author":"Torok","year":"1995","journal-title":"American Journal of Hematology"},{"issue":"22","key":"10.1002\/14651858.CD003595.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"8729","key":"10.1002\/14651858.CD003595.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/0140-6736(90)93214-A","article-title":"Cyclophosphamide for chronic relapsing thrombotic thrombocytopenic purpura","volume":"336","author":"Udvardy","year":"1990","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD003595.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2003-01-0193","article-title":"ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients","volume":"102","author":"Vesely","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1002\/14651858.CD003595.pub2-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003595","article-title":"Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura","author":"Elliott","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003595.pub2-BIB0053|cit53","first-page":"in press","article-title":"Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: A systematic review of randomized controlled trials","author":"Michael","year":"2008","journal-title":"American Journal of Kidney Diseases"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003595.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:40:33Z","timestamp":1782477633000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003595.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,1,21]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003595.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.721156369.793501517","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,21]]}}}